BIORA THERAPEUTICS, INC. Quarterly Selling and Marketing Expense in USD from Q2 2019 to Q1 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Summary
Biora Therapeutics, Inc. quarterly/annual Selling and Marketing Expense history and growth rate from Q2 2019 to Q1 2022.
  • Biora Therapeutics, Inc. Selling and Marketing Expense for the quarter ending March 31, 2022 was $13.5M, a 32.6% decline year-over-year.
  • Biora Therapeutics, Inc. Selling and Marketing Expense for the twelve months ending March 31, 2022 was -$1.74M, a 115% decline year-over-year.
  • Biora Therapeutics, Inc. annual Selling and Marketing Expense for 2021 was $4.76M, a 20% decline from 2020.
  • Biora Therapeutics, Inc. annual Selling and Marketing Expense for 2020 was $5.95M, a 89.9% decline from 2019.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Quarterly (USD)
Selling and Marketing Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2022 -$1.74M $13.5M -$6.5M -32.6% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $4.76M -$17.8M -$6.18M -53.3% Oct 1, 2021 Dec 31, 2021 10-K 2022-03-28
Q3 2021 $10.9M $573K -$990K -63.3% Jul 1, 2021 Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $11.9M $2.01M +$459K +29.7% Apr 1, 2021 Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $11.5M $20M +$5.52M +38.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $5.95M -$11.6M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-28
Q3 2020 $1.56M -$13.7M -89.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $1.55M -$13.1M -89.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $14.4M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q3 2019 $15.3M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $14.7M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.